Literature DB >> 33466498

The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis.

So Yeong Cheon1, Juhyun Song2.   

Abstract

Hepatic encephalopathy (HE) is one of the main consequences of liver disease and is observed in severe liver failure and cirrhosis. Recent studies have provided significant evidence that HE shows several neurological symptoms including depressive mood, cognitive dysfunction, impaired circadian rhythm, and attention deficits as well as motor disturbance. Liver disease is also a risk factor for the development of diabetes mellitus. Diabetic encephalopathy (DE) is characterized by cognitive dysfunction and motor impairment. Recent research investigated the relationship between metabolic changes and the pathogenesis of neurological disease, indicating the importance between metabolic organs and the brain. Given that a diverse number of metabolites and changes in the brain contribute to neurologic dysfunction, HE and DE are emerging types of neurologic disease. Here, we review significant evidence of the association between HE and DE, and summarise the common risk factors. This review may provide promising therapeutic information and help to design a future metabolic organ-related study in relation to HE and DE.

Entities:  

Keywords:  blood–brain barrier (BBB); brain-liver axis; diabetic encephalopathy; hepatic encephalopathy; neurotransmitter

Mesh:

Year:  2021        PMID: 33466498      PMCID: PMC7796499          DOI: 10.3390/ijms22010463

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  144 in total

1.  Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies.

Authors:  G Cheng; C Huang; H Deng; H Wang
Journal:  Intern Med J       Date:  2012-05       Impact factor: 2.048

Review 2.  Physiology and pharmacological role of the blood-brain barrier.

Authors:  Jacek Bernacki; Aleksandra Dobrowolska; Katarzyna Nierwińska; Andrzej Małecki
Journal:  Pharmacol Rep       Date:  2008 Sep-Oct       Impact factor: 3.024

Review 3.  Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure.

Authors:  Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2014-07-09

4.  Behavioral and biochemical characterization of rats treated chronically with thioacetamide: proposal of an animal model for hepatic encephalopathy associated with cirrhosis.

Authors:  Hiroshi Kawai; Takuya Ishibashi; Naomi Kudo; Yoichi Kawashima; Atsushi Mitsumoto
Journal:  J Toxicol Sci       Date:  2012       Impact factor: 2.196

5.  Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models.

Authors:  Slava Rom; Viviana Zuluaga-Ramirez; Sachin Gajghate; Alecia Seliga; Malika Winfield; Nathan A Heldt; Mikhail A Kolpakov; Yulia V Bashkirova; Abdel Karim Sabri; Yuri Persidsky
Journal:  Mol Neurobiol       Date:  2018-07-05       Impact factor: 5.590

6.  The liver.

Authors:  Elijah Trefts; Maureen Gannon; David H Wasserman
Journal:  Curr Biol       Date:  2017-11-06       Impact factor: 10.834

7.  Increased brain lactate is central to the development of brain edema in rats with chronic liver disease.

Authors:  Cristina R Bosoi; Claudia Zwingmann; Helen Marin; Christian Parent-Robitaille; Jimmy Huynh; Mélanie Tremblay; Christopher F Rose
Journal:  J Hepatol       Date:  2013-10-26       Impact factor: 25.083

Review 8.  Liver cirrhosis.

Authors:  Detlef Schuppan; Nezam H Afdhal
Journal:  Lancet       Date:  2008-03-08       Impact factor: 79.321

Review 9.  Role of Peripheral Inflammation in Hepatic Encephalopathy.

Authors:  Hassan Azhari; Mark G Swain
Journal:  J Clin Exp Hepatol       Date:  2018-06-25

Review 10.  Noradrenergic Modulation of Cognition in Health and Disease.

Authors:  Olga Borodovitsyna; Matthew Flamini; Daniel Chandler
Journal:  Neural Plast       Date:  2017-05-03       Impact factor: 3.599

View more
  3 in total

Review 1.  Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.

Authors:  Jeremy Louissaint; Sasha Deutsch-Link; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2022-08       Impact factor: 13.576

Review 2.  Hepatic Encephalopathy and Melatonin.

Authors:  Archana Arjunan; Dhiraj Kumar Sah; Young Do Jung; Juhyun Song
Journal:  Antioxidants (Basel)       Date:  2022-04-25

3.  Protective effect of probiotics and ascorbic acid on bile duct ligation-induced chronic hepatic encephalopathy in rats.

Authors:  Chirag Patel; Lalita Shahgond; Sanjeev Acharya; Sai Hs Boddu; Ketan Ranch
Journal:  Res Pharm Sci       Date:  2022-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.